Trial Information
Inclusion Criteria:
- You must have been diagnosed with bladder cancer that has recurred or moved to a new
part of the body.
- You must have at least one tumor that can be physically measured or scanned by x-ray.
- You may not have had previous chemotherapy (drug) treatment OR you have had surgery
followed by one chemotherapy treatment at least 4 months ago.
Exclusion Criteria:
- You may not have used an experimental medicine or device within the past month.
- Cancer that has spread to your brain.
- If you are unwilling or unable to take folic acid or vitamin B12 supplements.
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
4698
NCT ID:
NCT00035061
Start Date:
Completion Date:
Related Keywords:
- Urologic Neoplasms
- Metastases, Neoplasm
- Bladder Cancer
- Metastatic
- Recurrent
- Transitional cell carcinoma of the urothelium
- Neoplasms
- Carcinoma, Transitional Cell
- Neoplasm Metastasis
- Urologic Neoplasms
Name | Location |
|
Hinsdale, Illinois 60521 |
|
Fountain Valley, California 92708 |
|
Miami, Florida 33176 |
|
Cleveland, Ohio 44195 |
|
Philadelphia, Pennsylvania 19104 |
|
Nashville, Tennessee 37203-1632 |
|
Austin, Texas 78705 |
|
Seattle, Washington 98195 |
|
Louisville, Kentucky 40207 |
|
Kansas City, Kansas 66160 |
|
Omaha, Nebraska 68114 |
|
Boston, Massachusetts |
|
Indianapolis, Indiana |